Head of Investor Relations
Opus Genetics, Inc. (IRD)Equibles does not estimate personal net worth.
Get an email with a short summary when Opus Genetics, Inc. publishes a filing, an earnings call transcript or a press release.
Get IRD alertsJenny Coben is recorded as Head of Investor Relations at Opus Genetics, Inc. (IRD). Jenny Coben has spoken on 1 investor event across 1 company, most recently for Opus Genetics, Inc. on September 9, 2026. Opus Genetics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Opus Genetics, Inc. includes Dr. George Magrath (CEO and Board Member), George Magrath (CEO and Board Member), George Magrath, M.D., M.B.A., M.S. (CEO and Board Member) and 7 others.
“Good morning, and thank you for joining us on today's call to discuss top-line results from Cohort 1 of Opus Genetics' Best 1, Phase 1-2 clinical trial. Before we begin, I would like to remind you that during today's call, we will be making certain forward-looking statements.”
Biotechnology · Healthcare
Head of Investor Relations
